We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

61 hedge funds and large institutions have $88.2M invested in Akebia Therapeutics in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

7% more funds holding

Funds holding: 57 → 61 (+4)

7% less capital invested

Capital invested by funds: $94.4M → $88.2M (-$6.21M)

22% less call options, than puts

Call options by funds: $348K | Put options by funds: $445K

Holders
61
Holders Change
+4
Holders Change %
+7.02%
% of All Funds
1.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
23
Reduced
14
Closed
6
Calls
$348K
Puts
$445K
Net Calls
-$97K
Net Calls Change
-$381K

Top Buyers

1
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$2.74M
2
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$921K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$602K
4
ERSOT
Employees Retirement System of Texas
Texas
+$532K
5
EA
Emerald Advisers
Pennsylvania
+$457K

Top Sellers

1
HM
HealthCor Management
New York
-$2.67M
2
Millennium Management
Millennium Management
New York
-$1.01M
3
Franklin Resources
Franklin Resources
California
-$1.01M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$961K
5
CS
Candriam SCA
Luxembourg
-$890K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$250K -$5.39K -506 -2%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$234K +$201K +18,912 +901%
Charles Schwab
28
Charles Schwab
California
$233K +$100K +9,395 +82%
Millennium Management
29
Millennium Management
New York
$226K -$1.01M -94,680 -82%
Bank of America
30
Bank of America
North Carolina
$211K -$42.7K -4,010 -17%
DP
31
Dearborn Partners
Illinois
$200K +$39.4K +3,700 +26%
ProShare Advisors
32
ProShare Advisors
Maryland
$199K +$29.3K +2,750 +18%
Swiss National Bank
33
Swiss National Bank
Switzerland
$191K – – –
ARTA
34
A.R.T. Advisors
New York
$188K +$71.5K +6,712 +65%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$162K – – –
Group One Trading
36
Group One Trading
Illinois
$142K +$14.9K +1,397 +12%
RCM
37
Rotella Capital Management
Washington
$139K +$133K +12,500 New
UBS Group
38
UBS Group
Switzerland
$132K +$4.21K +395 +3%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$130K -$21.6K -2,025 -15%
TA
40
Teachers Advisors
New York
$123K – – –
AA
41
ALPS Advisors
Colorado
$112K +$107K +10,041 New
DekaBank Deutsche Girozentrale
42
DekaBank Deutsche Girozentrale
Germany
$106K +$101K +9,500 New
Wells Fargo
43
Wells Fargo
California
$91K +$12.2K +1,150 +17%
NFA
44
Nationwide Fund Advisors
Ohio
$62K -$306K -28,706 -84%
Fifth Third Bancorp
45
Fifth Third Bancorp
Ohio
$57K +$8.24K +774 +18%
AIG
46
American International Group
New York
$54.7K – – –
Deutsche Bank
47
Deutsche Bank
Germany
$49K -$59.1K -5,554 -56%
BA
48
BlackRock Advisors
Delaware
$41K +$4.9K +460 +14%
Citigroup
49
Citigroup
New York
$34K -$26.8K -2,516 -45%
PAM
50
Panagora Asset Management
Massachusetts
$32K +$30.6K +2,873 New
1
2
3

AKBA Hedge Fund Activity: Q1 2015 in Review

61 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q1 2015, worth a combined $88.2M — down 6.6% from $94.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AKBA positions and 6 closed out — a net gain of 4 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was Emerald Mutual Fund Advisers Trust, opening a new position worth an estimated $2.74M. The largest seller was HealthCor Management, cutting an estimated $2.67M.

  • 61 institutional investors held Akebia Therapeutics (AKBA) as of Q1 2015, up from 57 in Q4 2014.
  • Funds reported $88.2M of Akebia Therapeutics stock for Q1 2015, down 6.6% quarter-over-quarter.
  • 10 funds opened new Akebia Therapeutics positions in Q1 2015 and 6 closed out, a net change of +4 holders.
  • The largest Akebia Therapeutics buyer in Q1 2015 was Emerald Mutual Fund Advisers Trust, an estimated $2.74M added.
  • The largest Akebia Therapeutics seller in Q1 2015 was HealthCor Management, an estimated $2.67M sold.

Based on aggregated 13F filings for Q1 2015.